Zobrazeno 1 - 10
of 13
pro vyhledávání: '"I. A. Velizhanina"'
EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
Autor:
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 6, Pp 13-18 (2016)
Aim. To evaluate efficacy and safety of ramipril (Hartil, Egis) in treatment of patients with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical practice.Material and methods. 998 patients (42
Externí odkaz:
https://doaj.org/article/cac4a960937d47698a2e0f7d0a91d572
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 4, Pp 426-430 (2016)
Aim. To evaluate efficacy and safety of treatment with fixed combination of ramipril and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk in clinical practice. Material and methods.
Externí odkaz:
https://doaj.org/article/7e9b98fc58b14d0989005d1ab4adb975
Publikováno v:
Клиническая практика, Vol 8, Iss 4, Pp 51-55 (2017)
The study performs the results of our own researches regarding the method of intermittent normobaric hypoxic training as drug-free treatment in patients with arterial hypertension with low risk of cardiovascular complications. Clinical efficacy was a
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 4, Pp 426-430 (2016)
Aim. To evaluate efficacy and safety of treatment with fixed combination of ramipril and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk in clinical practice. Material and methods.
EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
Autor:
L. I. Gapon, I. A. Velizhanina, E. S. Velizhanina, A. V. Rudakov, M. I. Shupina, T. S. Bondarenko
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 5, Iss 6, Pp 13-18 (2016)
Aim. To evaluate efficacy and safety of ramipril (Hartil, Egis) in treatment of patients with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical practice.Material and methods. 998 patients (42
Publikováno v:
Klinicheskaia meditsina. 80(5)
A placebo-controlled parallel trial studied an antihypertensive action of interrupted normobaric hypoxia (INH) in 63 male patients with arterial hypertension (AH) of the first degree and low and moderate risk of vascular complications. The placebo gr
Autor:
I A, Velizhanina, O V, Evdokimova
Publikováno v:
Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. (1)
A randomized parallel study was performed to compare the antihypertensive effect of normobaric hypoxia and low energetic laser irradiation in 57 patients with essential hypertension stage I using 24-hour blood pressure monitoring. High hypotensive ef
Publikováno v:
Klinicheskaia meditsina. 79(1)
In a placebo-controlled study an antihypertensive activity of low-intensive laser radiation (LILR) was evaluated in 52 males with essential hypertension stage I. The placebo group consisted of 14 matched patients. LILR was used as monotherapy of 10 d
Publikováno v:
Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. (1)
The effect of low-energy laser irradiation used as monotherapy was studied in 42 patients with early essential hypertension. Hypotensive and antioxidant effects of laser therapy, its ability to decrease total peripheral resistance were more pronounce
Publikováno v:
Kardiologiia. 33(9)
A total of 110 young males suffering from hypertensive disease (HD) were studied. Out of them 21 patients had concurrent HD. As HD progresses, there is an accumulation of free cholesterol in the lipid bilayer of erythrocytic membranes, which promotes